Patrick W Whitworth
Overview
Explore the profile of Patrick W Whitworth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
390
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ganz P, Cecchini R, Julian T, Margolese R, Costantino J, Vallow L, et al.
Lancet
. 2015 Dec;
387(10021):857-65.
PMID: 26686960
Background: The NSABP B-35 trial compared 5 years of treatment with anastrozole versus tamoxifen for reducing subsequent occurrence of breast cancer in postmenopausal patients with ductal carcinoma in situ. This...
2.
Margolese R, Cecchini R, Julian T, Ganz P, Costantino J, Vallow L, et al.
Lancet
. 2015 Dec;
387(10021):849-56.
PMID: 26686957
Background: Ductal carcinoma in situ is currently managed with excision, radiotherapy, and adjuvant hormone therapy, usually tamoxifen. We postulated that an aromatase inhibitor would be safer and more effective. We...
3.
Lucci A, McCall L, Beitsch P, Whitworth P, Reintgen D, Blumencranz P, et al.
J Clin Oncol
. 2007 May;
25(24):3657-63.
PMID: 17485711
Purpose: The American College of Surgeons Oncology Group trial Z0011 was a prospective, randomized, multicenter trial comparing overall survival between patients with positive sentinel lymph nodes (SLNs) who did and...
4.
Evans H, Krag D, Teates C, Patterson J, Meijer S, Harlow S, et al.
Ann Surg Oncol
. 2003 May;
10(4):416-25.
PMID: 12734091
Background: Patients have traditionally been considered candidates for sentinel node biopsy (SNBx) only at the time of wide local excision (WLE). We hypothesized that patients with prior WLE may also...